NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

螺旋藻市場增長機會/增長預測(2020-2027):按類型/用途/形式/地區

Spirulina Market by Type, Application, and Formulation : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 1009359
出版日期 內容資訊 英文 246 Pages
商品交期: 2-3個工作天內
價格
螺旋藻市場增長機會/增長預測(2020-2027):按類型/用途/形式/地區 Spirulina Market by Type, Application, and Formulation : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2021年04月01日內容資訊: 英文 246 Pages
簡介

在預測期內,全球螺旋藻市場預計將以 10.5% 的複合年增長率增長,從 2019 年的 3.936 億美元增長到 2027 年的 8.9761 億美元。

螺旋藻的營養成分很高,它越來越多地用作膳食補充劑是推動市場增長的主要因素。由於癌症、心血管疾病和免疫紊亂的患病率不斷上升,消費者對螺旋藻的需求也在增加。此外,預計更高的醫療成本和更高的可支配收入等因素將推動市場增長。另一方面,資源限制預計將抑制進一步的市場增長。

本報告探討了全球螺旋藻市場,定義和概述了市場,分析了冠狀病毒病 (COVID-19) 和其他市場影響因素、法律環境、專利趨勢和案例研究。市場規模轉變/預測、細分按類型/用途/形式/地區/主要國家、競爭環境、主要公司簡介等各種類別進行匯總。

第 1 章介紹

第 2 章執行摘要

第 3 章市場概覽

  • 市場定義和範圍
  • 母市場概覽
  • 波特分析
  • 價格分析
  • 市場演變/行業路線圖
  • 專利分析
  • 市場份額分析
  • 價值鏈分析
  • 法律法規的影響
  • 行業問題分析
  • 案例研究
  • 市場趨勢
  • 誤識別
  • 企業支持
  • 生產策略 營銷策略
  • 歐洲的消費趨勢
  • 用於動物飼料
  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
  • COVID-19:影響分析

第 4 章市場分析/預測:按類型

  • 扁柏
  • Arslospyra Maxima
    • 主要趨勢/增長機會
    • 市場規模/預測:消費端
    • 市場規模/預測:生產方面
    • 市場分析:按國家/地區

第 5 章市場分析/預測:按應用

  • 中性藥
  • 化妝品
  • 食品/飲料
  • 動物飼料
  • 其他
    • 主要趨勢/增長機會
    • 市場規模/預測:消費端
    • 市場規模/預測:生產方面
    • 市場分析:按國家/地區

第 6 章市場分析/預測:按表格

  • 片劑和膠囊
  • 液體
  • 顆粒/膠凝劑
    • 主要趨勢/增長機會
    • 市場規模/預測:消費端
    • 市場規模/預測:生產方面
    • 市場分析:按國家/地區

第 7 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲/中東/非洲
    • 主要趨勢/增長機會
    • 市場規模/預測:按應用
    • 市場規模/預測:按類型
    • 市場規模/預測:按國家/地區

第八章公司簡介

  • ALGENOL BIOFUELS INC.
  • CABASSI & GIURIATI SPA
  • CYANOTECH CORPORATION
  • DDW INC.
  • DIC CORPORATION
  • DOHLER GmbH
  • DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.
  • ECHLORIAL
  • E.I.D. PARRY LIMITED
  • GIVAUDAN INTERNATIONAL SA
  • PROLGAE SPIRULINA SUPPLIES PVT. LTD.
  • POND TECHNOLOGIES INC.
  • SENSIENT TECHNOLOGIES CORPORATION
目錄
Product Code: LI_184222 / A03875

The global spirulina market was valued at $393.6 million in 2019, and is projected to reach $897.61 million by 2027, registering a CAGR of 10.5% from 2020 to 2027.

Spirulina is a natural algae powder known as cyanobacteria that includes potent level of proteins, antioxidants, and vitamin B and other nutrients. It exhibits various benefits such as lowering of LDL and triglyceride levels. It also exhibits anticancer properties, helps reduce blood pressure, is effective against anemia, and improves muscle strength.

Spirulina is used in various applications, such as food & beverages, dietary supplements, pharmaceuticals, animal & aquaculture, and cosmetic & personal care industry. In the last two years, multiple products were launched in the food & beverage industry in which it was used as a primary ingredient. Natural blue and green color produced from it is in high demand, and witnessed a strong market growth in the last two years.

The increase in use of spirulina as a dietary food supplement, owing to its high nutritional content is the major factor that drives the growth of the spirulina market. Furthermore, increase in adoption of healthy food in developed countries fuel the market growth in the food & beverages sector. The rise in prevalence of cancer, cardiovascular diseases, immune diseases, and other diseases boosts the demand for spirulina among its end users.

Furthermore, increase in healthcare expenditure and rise in disposable income among the population is anticipated to foster the market growth. However, limited resource of spirulina as it is extracted from freshwater sources that are available in very few areas hinders the market growth. Emerging economies such as India, China, Mexico, and Brazil are anticipated to provide new opportunities for the market growth during the forecast period.

The spirulina market is segmented into type, application, drug formulation, and region. By type, the market is bifurcated into Arthrospira Platensis and Arthrospira Platensis. By application, it is categorized into nutraceuticals, cosmetics, food & beverages, agriculture, feed, and others. By drug formulation, it is categorized into powder, tablet & capsule, liquid, and granule & gelling agent. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides a comprehensive analysis of the key players operating in the global spirulina market. These players include Cyanotech Corporation, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd., Algenol Biofuels Inc., Prolgae, Sensient Technologies Corporation, Parry Neutraceuticals, DDW Inc., Naturex S.A., and Algatec.

The other players operating in the global spirulina market include GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., Fraken Biochem Co., Ltd., and Far East Bio-Tec Co. Ltd.

Key benefits for stakeholders

The study presents an in-depth analysis of the global spirulina market along with the current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.

A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.

Identification of factors instrumental in changing the market scenario, rise in opportunities, and recognition of key players that can influence the market on a global and regional scale are provided in the report.

Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Key Market Segments

By Type

  • Arthrospira Platensis
  • Arthrospira Maxima

By Application

  • Nutraceuticals
  • Food & Beverages
  • Cosmetics
  • Animal Feed
  • Others

By Formulation

  • Powder
  • Tablet & Capsule
  • Liquid
  • Granule & Gelling Agent

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Rest of LAMEA
  • List of key players profiled in the report
  • Cyanotech Corporation
  • DIC Corporation
  • Cabassi & Giuriati SpA
  • DDW
  • DOHLER GmbH
  • Dongtai City Spirulina Bio-engineering Co., Ltd.
  • Echlorial
  • E.I.D. Parry Limited
  • Givaudan international SA
  • Prolgae Spirulina Supplies Pvt. Ltd.
  • Dongtai City Spirulina Bio-engineering Co., Ltd.
  • Algenol Biofuels Inc.
  • Pond Technologies Inc
  • Sensient Technologies Corporation
  • List of the other key players (not included in the report) GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., Fraken Biochem Co., Ltd., and Far East Bio-Tec Co. Ltd.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings
    • 2.1.1.Top investment pockets
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Parent Market Overview
  • 3.3.Key Forces Shaping Spirulina Market
    • 3.3.1.Moderate bargaining power of suppliers
    • 3.3.2.High bargaining power of buyers
    • 3.3.3.High threat of new entrants
    • 3.3.4.Moderate threat of substitutes
    • 3.3.5.High intensity of rivalry
  • 3.4.Pricing Analysis
    • 3.4.1.Pricing Analysis, By Region, 2019 & 2027
  • 3.5.Market evolution/Industry roadmap
  • 3.6.Patent Analysis
    • 3.6.1.By Region (2012-2020)
    • 3.6.2.By Applicant
    • 3.6.3.By Year
  • 3.7.Market share analysis
  • 3.8.Value Chain Analysis
  • 3.9.Impact of government regulations on the global spirulina market
  • 3.10.Industry pain point analysis
  • 3.11.Case Studies
    • 3.11.1.Case Study
  • 3.12.Market trends
    • 3.12.1.U.S.
    • 3.12.2.China
  • 3.13.False perception on the use of spirulina
  • 3.14.How the companies have reacted to the negative information
  • 3.15.Marketing strategies for production segments
  • 3.16.Trends for consumption in distinct European market
  • 3.17.Use of spirulina for animal feeding
  • 3.18.Market dynamics
    • 3.18.1.Drivers
      • 3.18.1.1.Increase in demand for natural ingredient
      • 3.18.1.2.Promotion of the production of spirulina by government
      • 3.18.1.3.R&D of spirulina as commercial products
    • 3.18.2.Restraints
      • 3.18.2.1.Impact on spirulina production due to climate change
    • 3.18.3.Opportunities
      • 3.18.3.1.Untapped markets in the developing countries
      • 3.18.3.2.Easy to cultivate due to development in cultivation technology
  • 3.19.Impact Analysis of COVID-19 on Spirulina Market

CHAPTER 4:SPIRULINA MARKET, BY TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast, by consumption side
    • 4.1.2.Market size and forecast, by production side
  • 4.2.Arthrospira Platensis
    • 4.2.1.Key market trends and opportunities
    • 4.2.2.Market size and forecast, by consumption side
    • 4.2.3.Market size and forecast, by production side
    • 4.2.4.Market analysis, by country
  • 4.3.Arthrospira maxima
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast, by consumption side
    • 4.3.3.Market size and forecast, by Production side
    • 4.3.4.Market analysis, by country

CHAPTER 5:SPIRULINA MARKET, BY APPLICATION

  • 5.1.Overview
    • 5.1.1.Market size and forecast, by consumption side
    • 5.1.2.Market size and forecast, by production side
  • 5.2.Nutraceuticals
    • 5.2.1.Key market trends and opportunities
    • 5.2.2.Market size and forecast, by consumption side
    • 5.2.3.Market size and forecast, by production side
    • 5.2.4.Market analysis, by country
  • 5.3.Cosmetics
    • 5.3.1.Key market trends and opportunities
    • 5.3.2.Market size and forecast, by consumption side
    • 5.3.3.Market size and forecast, by production side
    • 5.3.4.Market analysis, by country
  • 5.4.Food & beverages
    • 5.4.1.Key market trends and opportunities
    • 5.4.2.Market size and forecast, by consumption side
    • 5.4.3.Market size and forecast, by production side
    • 5.4.4.Market analysis, by country
  • 5.5.Animal Feed
    • 5.5.1.Key market trends and opportunities
    • 5.5.2.Market size and forecast, by consumption side
    • 5.5.3.Market size and forecast, by production side
    • 5.5.4.Market analysis, by country
  • 5.6.Other Applications
    • 5.6.1.Key market trends and opportunities
    • 5.6.2.Market size and forecast, by consumption side
    • 5.6.3.Market size and forecast, by production side
    • 5.6.4.Market analysis, by country

CHAPTER 6:SPIRULINA MARKET, BY FORMULATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast, by consumption side
    • 6.1.2.Market size and forecast, by production side
  • 6.2.Powder
    • 6.2.1.Key market trends and opportunities
    • 6.2.2.Market size and forecast, by consumption side
    • 6.2.3.Market size and forecast, by production side
    • 6.2.4.Market analysis, by country
  • 6.3.Tablet & capsule
    • 6.3.1.Key market trends and opportunities
    • 6.3.2.Market size and forecast, by consumption side
    • 6.3.3.Market size and forecast, by production side
    • 6.3.4.Market analysis, by country
  • 6.4.Liquid
    • 6.4.1.Key market trends and opportunities
    • 6.4.2.Market size and forecast, by consumption side
    • 6.4.3.Market size and forecast, by production side
    • 6.4.4.Market analysis, by country
  • 6.5.Granule & gelling agent
    • 6.5.1.Key market trends and opportunities
    • 6.5.2.Market size and forecast, by consumption side
    • 6.5.3.Market size and forecast, by production side
    • 6.5.4.Market analysis, by country

CHAPTER 7:SPIRULINA MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
    • 7.1.2.Market size and forecast, by production side
  • 7.2.North America
    • 7.2.1.Key market trends and opportunities
    • 7.2.2.North America market size and forecast, by type
    • 7.2.3.North America market size and forecast, by application
    • 7.2.4.North America market size and forecast, by formulation
    • 7.2.5.North America market size and forecast, by country
      • 7.2.5.1.U.S. market size and forecast, by type
      • 7.2.5.2.U.S. market size and forecast, by application
      • 7.2.5.3.U.S. market size and forecast, by formulation
      • 7.2.5.4.Canada market size and forecast, by type
      • 7.2.5.5.Canada market size and forecast, by application
      • 7.2.5.6.Canada market size and forecast, by formulation
      • 7.2.5.7.Mexico market size and forecast, by type
      • 7.2.5.8.Mexico market size and forecast, by application
      • 7.2.5.9.Mexico market size and forecast, by formulation
  • 7.3.Europe
    • 7.3.1.Key market trends and opportunities
    • 7.3.2.Europe market size and forecast, by type
    • 7.3.3.Europe market size and forecast, by application
    • 7.3.4.Europe market size and forecast, by formulation
    • 7.3.5.Europe market size and forecast, by country
      • 7.3.5.1.Germany market size and forecast, by type
      • 7.3.5.2.Germany market size and forecast, by application
      • 7.3.5.3.Germany market size and forecast, by formulation
      • 7.3.5.4.France market size and forecast, by type
      • 7.3.5.5.France market size and forecast, by application
      • 7.3.5.6.France market size and forecast, by formulation
      • 7.3.5.7.UK market size and forecast, by type
      • 7.3.5.8.UK market size and forecast, by application
      • 7.3.5.9.UK market size and forecast, by formulation
      • 7.3.5.10.Italy market size and forecast, by type
      • 7.3.5.11.Italy market size and forecast, by application
      • 7.3.5.12.Italy market size and forecast, by formulation
      • 7.3.5.13.Spain market size and forecast, by type
      • 7.3.5.14.Spain market size and forecast, by application
      • 7.3.5.15.Spain market size and forecast, by formulation
      • 7.3.5.16.Rest of Europe market size and forecast, by type
      • 7.3.5.17.Rest of Europe market size and forecast, by application
      • 7.3.5.18.Rest of Europe market size and forecast, by formulation
  • 7.4.Asia-Pacific
    • 7.4.1.Key market trends and opportunities
    • 7.4.2.Asia-Pacific market size and forecast, by type
    • 7.4.3.Asia-Pacific market size and forecast, by application
    • 7.4.4.Asia-Pacific market size and forecast, by formulation
    • 7.4.5.Asia-Pacific market size and forecast, by country
      • 7.4.5.1.Japan market size and forecast, by type
      • 7.4.5.2.Japan market size and forecast, by application
      • 7.4.5.3.Japan market size and forecast, by formulation
      • 7.4.5.4.China market size and forecast, by type
      • 7.4.5.5.China market size and forecast, by application
      • 7.4.5.6.China market size and forecast, by formulation
      • 7.4.5.7.India market size and forecast, by type
      • 7.4.5.8.India market size and forecast, by application
      • 7.4.5.9.India market size and forecast, by formulation
      • 7.4.5.10.Australia market size and forecast, by type
      • 7.4.5.11.Australia market size and forecast, by application
      • 7.4.5.12.Australia market size and forecast, by formulation
      • 7.4.5.13.Rest of Asia-Pacific market size and forecast, by type
      • 7.4.5.14.Rest of Asia-Pacific market size and forecast, by application
      • 7.4.5.15.Rest of Asia-Pacific market size and forecast, by formulation
  • 7.5.LAMEA
    • 7.5.1.Key market trends and opportunities
    • 7.5.2.LAMEA market size and forecast, by application
    • 7.5.3.LAMEA market size and forecast, by formulation
    • 7.5.4.LAMEA market size and forecast, by country
      • 7.5.4.1.Brazil market size and forecast, by type
      • 7.5.4.2.Brazil market size and forecast, by application
      • 7.5.4.3.Brazil market size and forecast, by formulation
      • 7.5.4.4.South Africa market size and forecast, by type
      • 7.5.4.5.South Africa market size and forecast, by application
      • 7.5.4.6.South Africa market size and forecast, by formulation
      • 7.5.4.7.Rest of LAMEA market size and forecast, by type
      • 7.5.4.8.Rest of LAMEA market size and forecast, by application
      • 7.5.4.9.Rest of LAMEA market size and forecast, by formulation

CHAPTER 8:COMPANY PROFILES

  • 8.1.ALGENOL BIOFUELS INC.
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
  • 8.2.CABASSI & GIURIATI SPA
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Operating business segments
  • 8.3.CYANOTECH CORPORATION
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Business performance
    • 8.3.6.Key strategic moves and developments
  • 8.4.DDW INC.
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Operating business segments
    • 8.4.4.Product portfolio
  • 8.5.DIC CORPORATION
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Operating business segments
    • 8.5.4.Product portfolio
    • 8.5.5.Business performance
  • 8.6.DOHLER GmbH
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Operating business segments
    • 8.6.4.Product portfolio
  • 8.7.DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Operating business segments
    • 8.7.4.Product portfolio
  • 8.8.ECHLORIAL
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
  • 8.9.E.I.D. PARRY LIMITED
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Business performance
  • 8.10.GIVAUDAN INTERNATIONAL SA
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Operating business segments
    • 8.10.4.Product portfolio
    • 8.10.5.Business performance
  • 8.11.PROLGAE SPIRULINA SUPPLIES PVT. LTD.
    • 8.11.1.Company overview
    • 8.11.2.Company snapshot
    • 8.11.3.Operating business segments
    • 8.11.4.Product portfolio
  • 8.12.POND TECHNOLOGIES INC.
    • 8.12.1.Company overview
    • 8.12.2.Company snapshot
    • 8.12.3.Operating business segments
    • 8.12.4.Product portfolio
  • 8.13.SENSIENT TECHNOLOGIES CORPORATION
    • 8.13.1.Company overview
    • 8.13.2.Company snapshot
    • 8.13.3.Operating business segments
    • 8.13.4.Product portfolio
    • 8.13.5.Business performance

LIST OF TABLES

  • TABLE 01.CASE STUDY D
  • TABLE 02.GLOBAL SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027($MILLION)
  • TABLE 03.GLOBAL SPIRULINA MARKET, BY TYPE, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • TABLE 04.SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY REGION, BY CONSUMPTION SIDE, 2019-2027($MILLION)
  • TABLE 05.SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY REGION, BY CONSUMPTION SIDE, 2019-2027($MILLION)
  • TABLE 06.GLOBAL SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 07.GLOBAL SPIRULINA MARKET, BY APPLICATION, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 08.SPIRULINA MARKET FOR NUTRACEUTICALS, BY CONSUMPTION SIDE, BY REGION, 2019-2027, ($MILLION)
  • TABLE 09.SPIRULINA MARKET FOR COSMETICS, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 10.SPIRULINA MARKET FOR FOOD & BEVERAGES, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 11.SPIRULINA MARKET FOR ANIMAL FEED, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 12.SPIRULINA MARKET FOR OTHER APPLICATIONS, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 13.GLOBAL SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 14.GLOBAL SPIRULINA MARKET, BY FORMULATION, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 15.SPIRULINA MARKET FOR POWDER, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 16.SPIRULINA MARKET FOR TABLET & CAPSULE, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 17.SPIRULINA MARKET FOR LIQUID, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 18.SPIRULINA MARKET FOR GRANULE & GELLING AGENT, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 19.SPIRULINA MARKET, BY REGION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 20.SPIRULINA MARKET, BY REGION, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 21.SPIRULINA MARKET, BY REGION, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 22.NORTH AMERICA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 23.NORTH AMERICA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 24.NORTH AMERICA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 25.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 26.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 27.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 28.U.S. SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 29.U.S. SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 30.U.S. SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 31.CANADA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 32.CANADA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 33.CANADA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 34.MEXICO SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 35.MEXICO SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 36.MEXICO SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 37.EUROPE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 38.EUROPE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 39.EUROPE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 40.EUROPE SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 41.EUROPE SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 42.EUROPE SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 43.GERMANY SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 44.GERMANY SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 45.GERMANY SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 46.FRANCE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 47.FRANCE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 48.FRANCE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 49.UK SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 50.UK SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 51.UK SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 52.ITALY SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 53.ITALY SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 54.ITALY SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 55.SPAIN SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 56.SPAIN SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 57.SPAIN SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 58.REST OF EUROPE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 59.REST OF EUROPE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 60.REST OF EUROPE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 61.ASIA-PACIFIC SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 62.ASIA-PACIFIC SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 63.ASIA-PACIFIC SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 64.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 65.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 66.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 67.JAPAN SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 68.JAPAN SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 69.JAPAN SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 70.CHINA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 71.CHINA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 72.CHINA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 73.INDIA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 74.INDIA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 75.INDIA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 76.AUSTRALIA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 77.AUSTRALIA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 78.AUSTRALIA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 79.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 80.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 81.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 82.LAMEA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 83.LAMEA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 84.LAMEA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 85.LAMEA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 86.LAMEA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019-2027, (TONS)
  • TABLE 87.LAMEA SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019-2027, ($MILLION)
  • TABLE 88.BRAZIL SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 89.BRAZIL SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 90.BRAZIL SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 91.SOUTH AFRICA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 92.SOUTH AFRICA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 93.SOUTH AFRICA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 94.REST OF LAMEA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 95.REST OF LAMEA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 96.REST OF LAMEA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019-2027, ($MILLION)
  • TABLE 97.ALGENOL: COMPANY SNAPSHOT
  • TABLE 98.ALGENOL: OPERATING SEGMENTS
  • TABLE 99.ALGENOL: PRODUCT PORTFOLIO
  • TABLE 100.CABASSI & GIURIATI: COMPANY SNAPSHOT
  • TABLE 101.CABASSI & GIURIATI: OPERATING SEGMENTS
  • TABLE 102.CYANOTECH: COMPANY SNAPSHOT
  • TABLE 103.CYANOTECH: OPERATING SEGMENTS
  • TABLE 104.CYANOTECH: PRODUCT PORTFOLIO
  • TABLE 105.DDW INC: COMPANY SNAPSHOT
  • TABLE 106.DDW INC: OPERATING SEGMENTS:
  • TABLE 107.DDW INC: PRODUCT PORTFOLIO
  • TABLE 108.DIC: COMPANY SNAPSHOT
  • TABLE 109.DIC: OPERATING SEGMENTS
  • TABLE 110.DIC: PRODUCT PORTFOLIO
  • TABLE 111.DOHLER: COMPANY SNAPSHOT
  • TABLE 112.DOHLER: OPERATING SEGMENTS
  • TABLE 113.DOHLER: PRODUCT PORTFOLIO
  • TABLE 114.DONGTAI: COMPANY SNAPSHOT
  • TABLE 115.DONGTAI: OPERATING SEGMENTS
  • TABLE 116.DONGTAI: PRODUCT PORTFOLIO
  • TABLE 117.ECHLORIAL: COMPANY SNAPSHOT
  • TABLE 118.ECHLORIAL: OPERATING SEGMENTS
  • TABLE 119.ECHLORIAL PRODUCT PORTFOLIO
  • TABLE 120.PARRY: COMPANY SNAPSHOT
  • TABLE 121.PARRY: OPERATING SEGMENTS
  • TABLE 122.PARRY: PRODUCT PORTFOLIO
  • TABLE 123.GIVAUDAN: COMPANY SNAPSHOT
  • TABLE 124.GIVAUDAN: OPERATING SEGMENTS
  • TABLE 125.GIVAUDAN: PRODUCT PORTFOLIO
  • TABLE 126.PROLGAE: COMPANY SNAPSHOT
  • TABLE 127.PROLGAE: OPERATING SEGMENTS
  • TABLE 128.PROLGAE SPIRULINA SUPPLIES PVT. LTD: PRODUCT PORTFOLIO
  • TABLE 129.POND TECHNOLOGIES INC: COMPANY SNAPSHOT
  • TABLE 130.POND TECHNOLOGIES INC: OPERATING SEGMENTS
  • TABLE 131.POND TECHNOLOGIES INC: PRODUCT PORTFOLIO
  • TABLE 132.SENSIENT: COMPANY SNAPSHOT
  • TABLE 133.SENSIENT: OPERATING SEGMENTS
  • TABLE 134.SENSIENT: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.TOP INVESTMENT POCKETS, 2019
  • FIGURE 02.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 03.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 04.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 05.MODERATE THREAT OF SUBSTITUTES
  • FIGURE 06.HIGH INTENSITY OF RIVALRY
  • FIGURE 07.PRICING ANALYSIS, BY REGION, 2019 & 2027
  • FIGURE 08.PATENT ANALYSIS, BY REGION
  • FIGURE 09.PATENT ANALYSIS, BY APPLICANT
  • FIGURE 10.PATENT ANALYSIS, BY YEAR
  • FIGURE 11.MARKET SHARE ANALYSIS, 2019
  • FIGURE 12.VALUE CHAIN ANALYSIS
  • FIGURE 13.INDUSTRY PAIN POINT ANALYSIS
  • FIGURE 14.GLOBAL SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 16.GLOBAL SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 18.GLOBAL SPIRULINA MARKET FOR NUTRACEUTICALS, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR NUTRACEUTICALS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 20.GLOBAL SPIRULINA MARKET FOR COSMETICS, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR COSMETICS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 22.GLOBAL SPIRULINA MARKET FOR FOOD & BEVERAGES, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR FOOD & BEVERAGES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 24.GLOBAL SPIRULINA MARKET FOR ANIMAL FEED, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR ANIMAL FEED, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 26.GLOBAL SPIRULINA MARKET FOR OTHER SPIRULINA, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 28.GLOBAL SPIRULINA MARKET FOR POWDER, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR POWDER, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 30.GLOBAL SPIRULINA MARKET FOR TABLET & CAPSULE, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 31.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR TABLET & CAPSULE, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 32.GLOBAL SPIRULINA MARKET FOR LIQUID, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 33.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR LIQUID, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 34.GLOBAL SPIRULINA MARKET FOR GRANULE & GELLING, BY PRODUCTION SIDE, 2019-2027($MILLION)
  • FIGURE 35.COMPARATIVE SHARE ANALYSIS OF SPIRULINA MARKET FOR GRANULE & GELLING AGENT, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 36.CYANOTECH: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 37.CYANOTECH: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 38.CYANOTECH: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 39.DIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 40.DIC: REVENUE SHARE BY PRODUCT, 2019 (%)
  • FIGURE 41.DIC: REVENUE SHARE BY REGION, 2019 (%)
  • FIGURE 42.PARRY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 43.PARRY: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 44.PARRY: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 45.GIVAUDAN: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 46.GIVAUDAN: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 47.GIVAUDAN: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 48.SENSIENT: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 49.SENSIENT: REVENUE SHARE BY PRODUCT, 2020 (%)
  • FIGURE 50.SENSIENT: REVENUE SHARE BY REGION, 2020 (%)